LON:PXS Provexis (PXS) Share Price, News & Analysis GBX 0.90 +0.10 (+11.80%) As of 12:25 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarnings About Provexis Stock (LON:PXS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Provexis alerts:Sign Up Key Stats Today's Range 0.71▼ 0.9450-Day Range 0.76▼ 1.2052-Week Range 0.56▼ 1.55Volume1.09 million shsAverage Volume1.75 million shsMarket Capitalization£21.11 millionP/E RatioN/ADividend Yield5.06%Price TargetN/AConsensus RatingN/A Company Overview Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom. Read More Receive PXS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Provexis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PXS Stock News HeadlinesProvexis (PXS) AI Stock AnalysisNovember 11 at 11:07 PM | tipranks.comProvexis PLC Full Year Sales DeclineSeptember 30, 2026 | rttnews.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 13 at 1:00 AM | Behind the Markets (Ad)AIM Market Roundup: Ramsdens, Provexis, Pulsar HeliumJune 24, 2026 | ca.finance.yahoo.comProvexis Secures Shareholder Support and Advances in Chinese MarketNovember 21, 2025 | tipranks.comAIM Market Roundup: Provexis, Geo Exploration, SabienNovember 19, 2025 | sg.finance.yahoo.comProvexis Faces Temporary Trading Suspension Amid Financial Reporting DelaySeptember 30, 2025 | tipranks.comPhase I trial finds topical PXS-6302 generally well tolerated in established skin scarsSeptember 12, 2025 | msn.comSee More Headlines PXS Stock Analysis - Frequently Asked Questions How have PXS shares performed this year? Provexis' stock was trading at GBX 0.90 at the beginning of 2026. Since then, PXS stock has increased by 0.0% and is now trading at GBX 0.90. How were Provexis' earnings last quarter? Provexis plc (LON:PXS) posted its quarterly earnings data on Thursday, October, 1st. The company reported GBX (0.02) earnings per share for the quarter. Provexis had a negative trailing twelve-month return on equity of 44.68% and a negative net margin of 39.76%. How do I buy shares of Provexis? Shares of PXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings10/01/2026Today11/13/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolLON:PXS CIKN/A Webwww.provexis.org Phone+44-1753-861777FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£619.15 thousand Net Margins-39.76% Pretax MarginN/A Return on Equity-44.68% Return on Assets-56.14% Debt Debt-to-Equity RatioN/A Current Ratio1.79 Quick Ratio6.21 Sales & Book Value Annual Sales£1.26 million Price / Sales16.70 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 0.01 per share Price / Book104.92Miscellaneous Outstanding Shares2,345,891,000Free FloatN/AMarket Cap£21.11 million OptionableNot Optionable Beta0.66 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (LON:PXS) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredA little-known law has been quietly applied to your savings for years.Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution...Monetary Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PXS Stock Alerts